Adenovirus E3-6.7K protein is required in conjunction with the E3-RID protein complex for the internalization and degradation of TRAIL receptor 2
about
Modulation of tumor necrosis factor by microbial pathogens.Mechanisms of pathogenesis of emerging adenoviruses.A novel hybrid adenoretroviral vector with more extensive E3 deletion extends transgene expression in submandibular glands.No evidence of a death-like function for species B1 human adenovirus type 3 E3-9K during A549 cell line infection.The Biology of TRAIL and the Role of TRAIL-Based Therapeutics in Infectious DiseasesAdenovirus RIDalpha regulates endosome maturation by mimicking GTP-Rab7.Anticancer activity of oncolytic adenovirus vector armed with IFN-alpha and ADP is enhanced by pharmacologically controlled expression of TRAILDevelopment of transcriptionally regulated oncolytic adenoviruses.Therapeutic applications of TRAIL receptor agonists in cancer and beyond.Homologous recombination in E3 genes of human adenovirus species DTRAIL recombinant adenovirus triggers robust apoptosis in multidrug-resistant HL-60/Vinc cells preferentially through death receptor DR5Oncolytic adenoviral gene therapy in ovarian cancer: why we are not wasting our time.Engineering oncolytic viruses to exploit tumor specific defects in innate immune signaling pathways.Open reading frame E3-10.9K of subspecies B1 human adenoviruses encodes a family of late orthologous proteins that vary in their predicted structural features and subcellular localization.Deletion of the E3-6.7K/gp19K region reduces the persistence of wild-type adenovirus in a permissive tumor model in Syrian hamsters.Mechanism for removal of tumor necrosis factor receptor 1 from the cell surface by the adenovirus RIDalpha/beta complex.Identification of a novel immunosubversion mechanism mediated by a virologue of the B-lymphocyte receptor TACI.Adenoviromics: Mining the Human Adenovirus Species D Genome
P2860
Q21089629-3C1DBBA3-176B-4F6C-A849-A85A487647A7Q30238495-A3C12BCE-AFED-49B0-91BC-38C61B931898Q33586270-A88FBBB5-0A4C-4936-8BBC-60F60708815EQ34375562-8CF048A3-DCD5-4607-93BA-2D12A6DDB49DQ35172090-FACB341C-C8BA-4317-8541-E9670A588AB4Q36176585-27BC71E5-E52C-4205-9CA4-C1E95221A8F6Q36209190-DB36E621-A13D-49B6-B93D-C5E04CE8BBCEQ36318182-35EFB762-5BA8-4385-9A13-968B0D4F179CQ37114025-C9020641-EA6F-49F2-8F20-BA8A22A8495CQ37254362-1F012EB7-F7B7-43F8-BFFB-9E5AA7A5752DQ37322648-8636E4E9-E320-4821-835D-3E32989D74B4Q37448942-1CB01E2A-DCCE-4E26-8E98-79C22E56CD7EQ37564490-34C15E43-E41C-4F88-AA82-ED5C9682B93CQ39663386-1F9E8CB5-4BBA-4745-8C65-F422EDBF5ECEQ39881872-D793708D-C933-49F5-9453-698EB74305FCQ40361594-F8449BCE-DF6B-49E0-B064-3114288EDB61Q42146978-2AF17426-465C-4351-98DD-6BD86233B282Q57158379-692EDC3F-B8F3-4A3B-9F01-6978E5BEFA4C
P2860
Adenovirus E3-6.7K protein is required in conjunction with the E3-RID protein complex for the internalization and degradation of TRAIL receptor 2
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh
2004年學術文章
@zh-hant
name
Adenovirus E3-6.7K protein is ...... egradation of TRAIL receptor 2
@en
Adenovirus E3-6.7K protein is ...... gradation of TRAIL receptor 2.
@nl
type
label
Adenovirus E3-6.7K protein is ...... egradation of TRAIL receptor 2
@en
Adenovirus E3-6.7K protein is ...... gradation of TRAIL receptor 2.
@nl
prefLabel
Adenovirus E3-6.7K protein is ...... egradation of TRAIL receptor 2
@en
Adenovirus E3-6.7K protein is ...... gradation of TRAIL receptor 2.
@nl
P2093
P2860
P1433
P1476
Adenovirus E3-6.7K protein is ...... egradation of TRAIL receptor 2
@en
P2093
Ann E Tollefson
Drew L Lichtenstein
Karoly Toth
Konstantin Doronin
Mohan Kuppuswamy
William S M Wold
P2860
P304
12297-12307
P356
10.1128/JVI.78.22.12297-12307.2004
P407
P577
2004-11-01T00:00:00Z